Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Kudelka

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Current Opinion in Oncology|September 1, 1993
Systemic therapy for gynecologic cancerJ J Kavanagh, A P Kudelka
The New England Journal of Medicine|April 4, 1998
Complete remission of metastatic cervical cancer with the angiogenesis inhibitor TNP-470A P Kudelka, C F Verschraegen, E Loyer
Annals of the Academy of Medicine, Singapore|January 27, 1999
Topoisomerase-I inhibitors in gynaecologic tumoursC F Verschraegen, A P Kudelka, J J Kavanagh
Oncology (Williston Park, N.Y.)|September 3, 1998
Irinotecan in cervical cancerJ J Kavanagh, C F Verschraegen, A P Kudelka
Current Opinion in Obstetrics & Gynecology|February 1, 1997
Taxanes in ovarian cancer treatmentK Seetalarom, A P Kudelka, C F Verschraegen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Carboplatin dosimetry in renal failureA P Kudelka, Z M Siddik, O Balat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Paraneoplastic syndromes of gynecologic neoplasmsA A Ashour, C F Verschraegen, A P Kudelka, et al.
American Journal of Clinical Oncology|October 16, 1999
Tamoxifen-induced thrombocytopeniaJ C Yao, N Thomakos, P McLaughlin, et al.
European Journal of Gynaecological Oncology|October 31, 2000
Estrogen replacement therapy and ovarian cancerT Sittisomwong, A Suneja, A P Kudelka, et al.
Clinical Chemistry|December 1, 1988
Secretion of creatine kinase MB isoenzyme by an immature teratoma with predominant rhabdomyosarcomatous elementsK Emancipator, A P Kudelka, G Bradford, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Current Opinion in Oncology|September 1, 1993
Systemic therapy for gynecologic cancerJ J Kavanagh, A P Kudelka
The New England Journal of Medicine|April 4, 1998
Complete remission of metastatic cervical cancer with the angiogenesis inhibitor TNP-470A P Kudelka, C F Verschraegen, E Loyer
Annals of the Academy of Medicine, Singapore|January 27, 1999
Topoisomerase-I inhibitors in gynaecologic tumoursC F Verschraegen, A P Kudelka, J J Kavanagh
Oncology (Williston Park, N.Y.)|September 3, 1998
Irinotecan in cervical cancerJ J Kavanagh, C F Verschraegen, A P Kudelka
Current Opinion in Obstetrics & Gynecology|February 1, 1997
Taxanes in ovarian cancer treatmentK Seetalarom, A P Kudelka, C F Verschraegen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Carboplatin dosimetry in renal failureA P Kudelka, Z M Siddik, O Balat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Paraneoplastic syndromes of gynecologic neoplasmsA A Ashour, C F Verschraegen, A P Kudelka, et al.
American Journal of Clinical Oncology|October 16, 1999
Tamoxifen-induced thrombocytopeniaJ C Yao, N Thomakos, P McLaughlin, et al.
European Journal of Gynaecological Oncology|October 31, 2000
Estrogen replacement therapy and ovarian cancerT Sittisomwong, A Suneja, A P Kudelka, et al.
Clinical Chemistry|December 1, 1988
Secretion of creatine kinase MB isoenzyme by an immature teratoma with predominant rhabdomyosarcomatous elementsK Emancipator, A P Kudelka, G Bradford, et al.
Pageof 11